About Conference

Join us for the 10th World Conference on Breast and Cervical Cancer, taking place on March 24-25, 2025, in the beautiful city of Paris, France. This year’s conference will revolve around the theme, "Transformative Approaches in Breast and Cervical Cancer: Personalized Care and Global Collaboration," spotlighting the latest advancements and ongoing research in the field. BRECECAN 2025 aims to bring together global experts and stakeholders in breast and cervical cancer to advance scientific knowledge, share best practices, and foster collaborations that ultimately benefit patients worldwide. Attendees can look forward to engaging presentations by renowned scientists and researchers, showcasing groundbreaking research and promoting collaborative efforts. This conference serves as an invaluable platform for the exchange of knowledge, networking opportunities, and the advancement of strategies aimed at improving patient outcomes in breast and cervical cancer.

Taget Audience

• Oncologists
• Gynecologists
• Radiologists
• Pathologists
• Nurses and Nurse Practitioners
• Genetic Counselors
• Medical Researchers focusing on breast and cervical cancer
• Epidemiologists
• Public Health Experts
• Medical and nursing students
• Hospital Administrators
• Policy Makers
• Healthcare Executives

Sessions & Tracks

Track 01 Carcinogenesis and Cancer Epidemiology

Carcinogenesis is the process by which normal cells become cancerous due to genetic mutations and environmental factors such as carcinogens. Cancer epidemiology studies the distribution and determinants of cancer in populations, identifying risk factors to inform prevention strategies. Understanding these mechanisms is essential for advancing cancer prevention and treatment efforts.

• Mechanisms of Metastasis
• Genetic and Molecular Mechanisms
• Epigenetics

Track 02 Cancer Screening and Detection

Screening and early detection of cancer are vital components in improving survival rates and treatment outcomes. By identifying cancer at an early stage, patients often have a significantly higher chance of successful treatment and reduced mortality rates. Advances in technology, including genomic testing and artificial intelligence, are enhancing screening methods, leading to improved accuracy and early detection. Overall, engaging in proactive discussions with healthcare providers about tailored screening plans is essential for effective cancer prevention.

• Mammography
• Colonoscopy
• Pap Smear and HPV

Track 03: Breast cancer (Breast Carcinoma):

Breast cancer (breast carcinoma) is a malignant tumor that originates from the cells of the breast. It is the most common cancer in women worldwide, though it can also affect men. Breast cancer arises when genetic mutations within breast cells lead to uncontrolled cell division and growth, eventually forming a mass or lump known as a tumor.

• Staging and Grading of Breast Cancer
• Research and Advances in Breast Cancer

Track 04: Molecular Biology and Genetics of Breast Cancer

The molecular biology and genetics of breast cancer focus on the intricate mechanisms and genetic alterations that contribute to the development, progression, and spread of the disease. Several key genes and pathways are implicated in breast cancer, making it a highly heterogeneous disease with multiple subtypes, each requiring specific treatment approaches.

• BRCA1/BRCA2 mutations
• TP53 mutations
• HER2 gene amplification

Track 05: Cervical Cancer

Cervical cancer is a malignant disease that occurs in the cells of the cervix, most commonly caused by persistent infection with high-risk strains of the human papillomavirus (HPV), particularly types 16 and 18. It develops slowly, starting with precancerous changes in the cervix. Early symptoms may include abnormal vaginal bleeding, pelvic pain, and pain during intercourse, though many cases remain asymptomatic in the early stages.Early detection significantly improves survival rates, making routine screening and vaccination key in reducing the global burden of cervical cancer.

• Radiation Therapy
• Chemotherapy
• Targeted or immunotherapy

Track 06: Comprehensive Treatment Modalities for Breast Cancer

Experts will provide an overview of treatment options for breast cancer, including surgical interventions, chemotherapy, hormone therapy, and emerging targeted therapies. The session will highlight the importance of personalized treatment plans and recent advancements in the field.

Track 07: Treatment Modalities for Cervical Cancer

Participants will explore treatment options for cervical cancer, including surgical treatments, chemotherapy, and radiation therapy. This session will also cover emerging therapies, such as immunotherapy and targeted treatments, and discuss their potential impact on patient outcomes.

Track 08: Hormonal Influences and Endocrine Therapy

Hormonal influences play a crucial role in the development and progression of certain cancers, particularly breast and cervical cancers. These cancers often rely on hormones, such as estrogen and progesterone, for their growth. Understanding these hormonal influences has led to the development of endocrine therapy, a targeted treatment approach aimed at blocking or lowering hormone levels to inhibit cancer cell growth.

• Selective Estrogen Receptor Modulators (SERMs)
• Endocrine Therapy for Cervical Cancer
• Estrogen Receptor Downregulators (ERDs)

Track 09: Patient-Centered Care and Quality of Life

Participants will focus on the psychosocial aspects of survivorship in both breast and cervical cancer. This track will address support systems, mental health considerations, and strategies for managing treatment-related side effects, emphasizing the importance of holistic care for patients.

Track 10: Health Disparities and Access to Care

This track will address disparities in breast and cervical cancer incidence and outcomes among various populations. Barriers to accessing care, including socioeconomic, racial, and geographic factors, will be analyzed, along with initiatives aimed at improving access to screening and treatment for underserved communities.

Track 11: Public Health Initiatives and Education

Experts will present effective public health campaigns aimed at increasing awareness and promoting screening for both breast and cervical cancer. The importance of community outreach programs and engaging high-risk populations through tailored health education initiatives will be discussed.

Track 12: Innovative Research and Future Directions in Breast Cancer

This track will highlight the latest advancements in research for breast cancer, including novel therapies and clinical trials. Discussions will cover the role of precision medicine and genomic profiling in shaping future treatment strategies, focusing on how these advancements can lead to better patient outcomes.

Track 13: Integrative and Supportive Care

Participants will learn about complementary therapies that can enhance the quality of life for breast and cervical cancer patients. This session will cover nutrition, exercise, and psychological support, as well as the importance of palliative care in managing symptoms and improving patient comfort.

Track 14: International Perspectives on Cancer Care

This track will offer insights into how different countries address breast and cervical cancer prevention and treatment. Successful case studies and collaborative efforts in global cancer control programs will be highlighted, showcasing best practices and lessons learned.

Track 15: Ethical Considerations in Cancer Care

Experts will discuss ethical dilemmas encountered in breast and cervical cancer research and treatment, emphasizing the importance of informed consent, patient autonomy, and the balance between innovation and ethical responsibilities in clinical practice.

Track 16: Advocacy and Policy in Cancer Care

Advocacy and policy play vital roles in shaping cancer care by influencing healthcare systems, funding, research priorities, and patient access to treatment. Effective advocacy efforts aim to raise awareness about cancer-related issues, promote equitable access to care, and ensure that patients' voices are heard in the decision-making processes that affect their health outcomes.

• Patient Rights and Empowerment
• International and Global Health Initiatives
• Support for Survivorship